Doctor-led aesthetics in Sutton Coldfield
MDr MaryamAesthetics

Anti-wrinkle treatments

Masseter treatment for jaw slimming: why function must be assessed first

A wider lower face is not always caused by large masseter muscles, and reducing muscle activity can affect chewing as well as contour. Assessment should separate aesthetic goals from dental or jaw-joint problems.

5 minute read

A wide lower face has more than one cause

The masseters are strong muscles at the sides of the jaw that help close the mouth and chew. They may become prominent through anatomy, muscle use or clenching, but lower-face width also reflects bone shape, facial fat, skin laxity, swelling and natural asymmetry. Looking square in one photograph does not diagnose masseter hypertrophy.

Prescription anti-wrinkle treatment can reduce selected muscle activity and may gradually make genuine muscle prominence less visible. It cannot narrow the jawbone, remove fat, tighten loose skin or correct every asymmetry. Treating the wrong cause may produce little useful change, so examination at rest and while clenching is more informative than choosing treatment from an image.

Jaw shape and jaw symptoms are different questions

Some people seeking a slimmer jaw also grind their teeth, wake with jaw fatigue or have pain around the jaw joint. These symptoms can have several causes and do not prove that a cosmetic injection is the right treatment. Tooth wear, a changed bite, locking, limited opening or one-sided swelling may justify dental or medical assessment.

Reducing masseter activity is not a complete diagnostic or dental plan for bruxism. Splints, behaviour change, sleep assessment, physiotherapy or treatment of a dental problem may be considered depending on the cause. A cosmetic goal and a pain or grinding problem should therefore be assessed separately, even when both involve the same muscle.

What can current studies support?

A recent systematic review combined five randomised, placebo-controlled trials involving 536 participants with masseter hypertrophy. Treatment was associated with short-term improvements in muscle prominence, measured muscle thickness and satisfaction, but results varied substantially between studies. The authors could not define an optimal protocol and called for standardised trials with longer follow-up.

A 12-month randomised study of 187 healthy adults also found reductions in lower-face volume and masseter prominence compared with placebo. However, participants had marked or very marked bilateral prominence and met study criteria; the findings cannot be applied automatically to somebody whose width comes mainly from bone, fat or skin. Improvement is temporary and an individual result cannot be guaranteed.

Function and longer-term uncertainty matter

Because the masseter is a chewing muscle, a slimmer contour can come with reduced function. A small randomised trial found that repeated treatment changed muscle thickness and electrical activity, although measured chewing performance did not differ significantly. In a larger 12-month imaging study, the most reported treatment-related event was a mastication disorder, affecting 6% of treated participants.

That imaging study found no detectable difference from placebo in predefined jawbone measurements after one or two treatments over a year, which is reassuring within that period. It also stated that effects emerging after 12 months could not be excluded. Evidence about many repeated cosmetic treatments over several years remains limited, so ongoing review is more appropriate than assuming indefinite treatment is harmless.

Downtime and adverse effects

Short-term effects can include tenderness, redness, swelling, bruising or headache. Chewing may feel tired or weak, particularly with firm food. Unwanted effects can include smile asymmetry, a change in facial expression, uneven contour, hollowing or greater visibility of skin laxity. The effect cannot be removed immediately and usually changes gradually as muscle activity returns.

The MHRA reported in July 2026 that serious symptoms caused by spread beyond the treatment area are rare but can occur up to four weeks later. Difficulty swallowing, slurred speech, breathing difficulty or widespread muscle weakness requires immediate medical help. Increasing pain, marked swelling, fever or a new neurological symptom also needs prompt clinical assessment.

Consultation should protect both appearance and function

Assessment should cover the desired change, bite and chewing symptoms, jaw-joint history, dental care, previous treatment, medical conditions, medicines and allergies. Neuromuscular disorders, previous swallowing or breathing difficulty, active infection, pregnancy or breastfeeding may change suitability or mean treatment should not proceed. Referral for dental or medical assessment can be the safest next step.

The GMC requires a physical examination before a doctor prescribes an injectable cosmetic medicine; remote prescribing is not acceptable. A responsible plan explains the limited evidence, alternatives, likely time course, possible functional trade-offs, downtime and review arrangements. It may recommend a conservative approach, treatment of a different cause or no cosmetic treatment at all.

← Back to the journal

Personalised medical assessment

Questions about treatment?

Book a consultation to discuss your concerns, health and treatment options without pressure.

Free consultation – a £1 booking fee secures your appointment